Venous thromboembolism (VTE) is a chronic illness that includes pulmonary embolism (PE) and deep vein thrombosis (DVT), and many risk factors are associated. Anticoagulation therapy remains the cornerstone of venous thromboembolism management, and the duration of anticoagulation depends on the risk of venous thromboembolism. We report a case of a female with a combined heterozygosity of factor V Leiden and G20210A prothrombin gene mutation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559759PMC
http://dx.doi.org/10.7759/cureus.44835DOI Listing

Publication Analysis

Top Keywords

venous thromboembolism
16
combined heterozygosity
8
heterozygosity factor
8
factor leiden
8
leiden g20210a
8
g20210a prothrombin
8
prothrombin gene
8
gene mutation
8
mutation patient
4
venous
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!